ジスキネジア(Dyskinesia):治療薬開発パイプライン動向(2015年上半期版)...市場調査レポートについてご紹介

【英文タイトル】Dyskinesia - Pipeline Review, H1 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 7
List of Figures 8
Introduction 9
Global Markets Direct Report Coverage 9
Dyskinesia Overview 10
Therapeutics Development 11
Pipeline Products for Dyskinesia – Overview 11
Pipeline Products for Dyskinesia – Comparative Analysis 12
Dyskinesia – Therapeutics under Development by Companies 13
Dyskinesia – Therapeutics under Investigation by Universities/Institutes 16
Dyskinesia – Pipeline Products Glance 17
Late Stage Products 17
Clinical Stage Products 18
Early Stage Products 19
Dyskinesia – Products under Development by Companies 20
Dyskinesia – Products under Investigation by Universities/Institutes 23
Dyskinesia – Companies Involved in Therapeutics Development 24
Adamas Pharmaceuticals, Inc. 24
Addex Therapeutics Ltd 25
Advicenne Pharma 26
Amarantus Bioscience Holdings, Inc. 27
Astraea Therapeutics, LLC 28
Auspex Pharmaceuticals, Inc. 29
BioMarin Pharmaceutical Inc. 30
Catalyst Pharmaceutical Partners, Inc. 31
Contera Pharma ApS 32
EpiVax, Inc. 33
Heptares Therapeutics Ltd. 34
Integrative Research Laboratories Sweden AB 35
Ipsen S.A. 36
Medicure Inc. 37
Medy-Tox Inc. 38
Merz Pharmaceuticals GmbH 39
Neurim Pharmaceuticals Ltd 40
Neurocrine Biosciences, Inc. 41
Neurolixis Inc. 42
Novartis AG 43
Osmotica Pharmaceutical Corp. 44
Otsuka Holdings Co., Ltd. 45
Santhera Pharmaceuticals Holding AG 46
SciFluor Life Sciences, LLC 47
Synchroneuron Inc. 48
Targacept, Inc. 49
Upsher-Smith Laboratories, Inc. 50
Dyskinesia – Therapeutics Assessment 51
Assessment by Monotherapy Products 51
Assessment by Combination Products 52
Assessment by Target 53
Assessment by Mechanism of Action 55
Assessment by Route of Administration 57
Assessment by Molecule Type 59
Drug Profiles 61
(dextromethorphan hydrobromide + quinidine sulfate) – Drug Profile 61
Product Description 61
Mechanism of Action 61
R&D Progress 61
abobotulinumtoxin A – Drug Profile 63
Product Description 63
Mechanism of Action 63
R&D Progress 63
abobotulinumtoxin A next generation – Drug Profile 65
Product Description 65
Mechanism of Action 65
R&D Progress 65
acamprosate calcium SR – Drug Profile 66
Product Description 66
Mechanism of Action 66
R&D Progress 66
ADV-6979 – Drug Profile 68
Product Description 68
Mechanism of Action 68
R&D Progress 68
amantadine hydrochloride ER – Drug Profile 69
Product Description 69
Mechanism of Action 69
R&D Progress 69
amantadine hydrochloride ER – Drug Profile 71
Product Description 71
Mechanism of Action 71
R&D Progress 71
AQW-051 – Drug Profile 72
Product Description 72
Mechanism of Action 72
R&D Progress 72
AT-127 – Drug Profile 73
Product Description 73
Mechanism of Action 73
R&D Progress 73
AT-326 – Drug Profile 74
Product Description 74
Mechanism of Action 74
R&D Progress 74
AT-403 – Drug Profile 75
Product Description 75
Mechanism of Action 75
R&D Progress 75
AVP-786 – Drug Profile 76
Product Description 76
Mechanism of Action 76
R&D Progress 76
befiradol – Drug Profile 78
Product Description 78
Mechanism of Action 78
R&D Progress 78
CPP-115 – Drug Profile 79
Product Description 79
Mechanism of Action 79
R&D Progress 79
dipraglurant ER – Drug Profile 81
Product Description 81
Mechanism of Action 81
R&D Progress 81
dipraglurant IR – Drug Profile 82
Product Description 82
Mechanism of Action 82
R&D Progress 82
Drugs for Dyskinesia – Drug Profile 83
Product Description 83
Mechanism of Action 83
R&D Progress 83
Drugs for Tardive Dyskinesia – Drug Profile 84
Product Description 84
Mechanism of Action 84
R&D Progress 84
dutetrabenazine ER – Drug Profile 85
Product Description 85
Mechanism of Action 85
R&D Progress 85
eltoprazine – Drug Profile 86
Product Description 86
Mechanism of Action 86
R&D Progress 86
fipamezole – Drug Profile 88
Product Description 88
Mechanism of Action 88
R&D Progress 88
HTL-14242 – Drug Profile 90
Product Description 90
Mechanism of Action 90
R&D Progress 90
IRL-790 – Drug Profile 91
Product Description 91
Mechanism of Action 91
R&D Progress 91
JM-010 – Drug Profile 92
Product Description 92
Mechanism of Action 92
R&D Progress 92
MRZ-8676 – Drug Profile 93
Product Description 93
Mechanism of Action 93
R&D Progress 93
naluzotan – Drug Profile 94
Product Description 94
Mechanism of Action 94
R&D Progress 94
Neu-120 – Drug Profile 95
Product Description 95
Mechanism of Action 95
R&D Progress 95
Neu-240 – Drug Profile 96
Product Description 96
Mechanism of Action 96
R&D Progress 96
onabotulinumtoxin A – Drug Profile 97
Product Description 97
Mechanism of Action 97
R&D Progress 97
onabotulinumtoxin A – Drug Profile 98
Product Description 98
Mechanism of Action 98
R&D Progress 98
PEUN-3 – Drug Profile 99
Product Description 99
Mechanism of Action 99
R&D Progress 99
RG-2833 – Drug Profile 100
Product Description 100
Mechanism of Action 100
R&D Progress 100
Small Molecule for Dyskinesia – Drug Profile 102
Product Description 102
Mechanism of Action 102
R&D Progress 102
Small Molecule for Dyskinesia and Hyperkinesia – Drug Profile 103
Product Description 103
Mechanism of Action 103
R&D Progress 103
Small Molecules to Antagonize Metabotropic Glutamate Receptor 5 (mGluR5) for Dyskinesia – Drug Profile 104
Product Description 104
Mechanism of Action 104
R&D Progress 104
Tardoxal – Drug Profile 105
Product Description 105
Mechanism of Action 105
R&D Progress 105
TC-8831 – Drug Profile 106
Product Description 106
Mechanism of Action 106
R&D Progress 106
valbenazine – Drug Profile 107
Product Description 107
Mechanism of Action 107
R&D Progress 107
Dyskinesia – Recent Pipeline Updates 109
Dyskinesia – Dormant Projects 136
Dyskinesia – Discontinued Products 138
Dyskinesia – Product Development Milestones 139
Featured News & Press Releases 139
Feb 10, 2015: Amarantus Announces Publication in BRAIN of Eltoprazine Phase 2a Clinical Study for Treating Parkinson’s Disease Levodopa-Induced Dyskinesia 139
Feb 09, 2015: Adamas Pharmaceuticals’ Phase 2/3 Clinical Study Published in Movement Disorders 140
Feb 03, 2015: Auspex Pharmaceuticals Completes Enrollment in a Pivotal Clinical Trial of SD-809 in Tardive Dyskinesia 141
Jan 19, 2015: Addex and Dystonia Medical Research Foundation Announce Partnership to Explore the Therapeutic use of Dipraglurant in the Treatment of Dystonia 142
Jan 12, 2015: Auspex Announces Favorable Topline Results From Thorough QT Clinical Trial of SD-809 143
Jan 08, 2015: Amarantus to Participate in the Eighth Annual OneMedForum Conference on January 12 – 13, 2015 144
Oct 30, 2014: Auspex Pharmaceuticals Initiates Second Pivotal Clinical Trial for SD-809 in Tardive Dyskinesia 144
Oct 30, 2014: Neurocrine Biosciences Receives Breakthrough Therapy Designation for NBI-98854 in Tardive Dyskinesia 145
Oct 28, 2014: Adamas Pharmaceuticals Expands Its Phase 3 Program With ADS-5102 for the Treatment of Levodopa-induced Dyskinesia in Patients With Parkinson’s Disease 146
Oct 20, 2014: Neurocrine Announces Initiation Of Phase III Study For VMAT2 Inhibitor NBI-98854 147
Appendix 148
Methodology 148
Coverage 148
Secondary Research 148
Primary Research 148
Expert Panel Validation 148
Contact Us 148
Disclaimer 149


【レポート販売概要】

■ タイトル:ジスキネジア(Dyskinesia):治療薬開発パイプライン動向(2015年上半期版)
■ 英文:Dyskinesia - Pipeline Review, H1 2015
■ 発行日:2015年3月11日
■ 調査会社:Global Markets Direct
■ 商品コード:GMDHC6258IDB
■ 調査対象地域:グローバル
  • Factor Assay:医療検査市場2014
    The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and Factor Assays testing specifically, will become more standardized, offeri …
  • 自動車タイヤの世界市場予測
    A tire is a circular component, which fits on a circular rim and carries the vehicle load as well as it provides the vehicle, better road grip. The vehicle load is transferred through axles to the tire. The automotive tires are made up of synthetic rubber, wire, natural rubber and fabric. The tires are made up with ply cords and plies. The rim attached to the tire helps insert air pressure in the …
  • 微細セルポリウレタンフォームの世界市場:低密度フォーム、高密度フォーム
    The global microcellular polyurethane foam market was valued at USD 5.06 Billion in 2015, and is projected to reach USD 6.95 Billion by 2021, at a CAGR of 5.5% between 2016 and 2021. The market is projected witness significant growth in the coming years, owing to the rising demand for lightweight materials from various industries, such as automotive, aerospace, and construction. The automotive, bu …
  • ヨーロッパのEthylene-vinyl Acetate Copolymers市場
    The report provides a complete overview of the ethylene-vinyl acetate copolymers market in EU countries in a comprehensive and easily accessed format. Market current state, historical figures and future development are in the report. Scope The report gives in-depth analysis of the European Union market for ethylene-vinyl acetate copolymers with data for EU in total and by country Current statistic …
  • 世界のデンタル・インプラント及び義歯市場
    The market has a tremendous growth potential mainly due to the increasing demand from the developing Asian and South American nations. This increase in demand is attributed to the increasing purchasing power and also due to increasing consumer acceptance of advanced dental technologies. Besides the structural market drivers, there are strong geographic drivers for the growth of the dental implants …
  • 世界におけるカプセル内視鏡の製品パイプライン動向2015
    Capsule Endoscope Systems - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Capsule Endoscope Systems - Pipeline Review, 2015" provides an overview of Capsule Endoscope Systems currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews m …
  • OSS value chain
    As digital services and communication networks circle the globe, carriers and service providers face decisive challenges in managing their infrastructure which is expanding with exponential growth rates. Investing on advanced, next generation OSS platforms in the only way to deal with these challenges, however the value of deploying and running complex operating and business support systems depend …
  • 世界の産業自動化サービス市場動向(2014-2018)
    TechNavio's analysts forecast the Global Industrial Automation Services market to grow at a CAGR of 10.06 percent over the period 2013-2018. One of the key factors contributing to this market growth is the need to optimize the overall operational cost for end-users. The Global Industrial Automation Services market has also been witnessing the increasing demand of automation services from the APAC …
  • Helminthiasis:グローバル臨床試験レビューH1, 2013
    Helminthiasis Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Helminthiasis Global Clinical Trials Review, H1, 2013" provides data on the Helminthiasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Helminthiasis. It includes an overview of the trial numbers and their recruitment status as per the …
  • 世界のデータセンター市場動向(2012-2016)
    Introduction to the Market A data center is a centralized facility for data computing, processing, and storage. A data center facility contains high performance servers, networking equipment, storage arrays, and provides supporting services such as powering and cooling solutions. Data centers are either established by large scale enterprises or by a group of enterprises for centralization of the c …
  • GIS(地理情報システム)の世界市場2017-2021
    About GIS GIS (geographic information system) is a set of tools used to interpret business and geospatial data. It integrates hardware, software, data, and services for processing business and geographically referenced data. GIS digitizes the received geospatial data and processes them to provide the desired output. Sectors such as national government, transportation, natural resources, military/l …
  • 航空機リハービッシュ(改装)の世界市場2016-2020
    About the Aircraft Refurbishing Market Airline companies across the world seek to refurbish their aircraft with the latest upgrades to improve their operational efficiency, increase the lifespan of aircraft, and to perform cost-effective operations. Depending on the type of aircraft, different kinds of upgrading and modernization can be carried out on avionics as well as in aircraft cabin interior …
  • 黒鉛電極の世界市場2016-2020
    About Graphite Graphite is a crystalline form of carbon, which is a semimetal and a native element mineral. It is considered as one of the allotropes of carbon, and has distinct structure and properties. Graphite is the highest grade of coal, and has stable form of carbon under standard conditions. It has characteristics of metal and non-metal with high thermal and electrical conductivity. It is h …
  • 呼吸器診断の世界市場予測: 肺機能検査、イメージング検査、機械的検査、閉塞性睡眠時無呼吸(OSA)診断検査、従来式診断検査、分子診断検査
    The global respiratory diagnostics market is projected to reach USD 7.45 Billion by 2021 from USD 5.24 Billion in 2016, at a CAGR of 7.3% from 2016 to 2021. In this report, the global market is broadly segmented by product and service, test type, disease, end user, and region. Increasing prevalence of respiratory diseases, growing geriatric population, and technological advancements in respiratory …
  • ゼラチンの世界市場2017-2021
    About Gelatin Gelatin is a colorless, flavorless, semi-transparent, and brittle collagen product. It is a protein food product generally derived from the several animal sources. It is used in several applications as a stabilizer, thickener, and gelling agent. Gelatin is normally graded into categories as per its quality and strength, and the unit is named as 'bloom.' A greater bloom number signifi …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。